Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Operating Expenses: 2020-2025

Historic Operating Expenses for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to $46.7 million.

  • Maravai Lifesciences Holdings' Operating Expenses fell 76.40% to $46.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $464.3 million, marking a year-over-year increase of 4.34%. This contributed to the annual value of $494.8 million for FY2024, which is 54.34% up from last year.
  • According to the latest figures from Q3 2025, Maravai Lifesciences Holdings' Operating Expenses is $46.7 million, which was down 58.93% from $113.7 million recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Operating Expenses peaked at $208.0 million during Q4 2024, and registered a low of $46.7 million during Q3 2025.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Operating Expenses value was $82.9 million (recorded in 2024), while the average stood at $104.4 million.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Operating Expenses surged by 252.75% in 2021 and then slumped by 76.40% in 2025.
  • Maravai Lifesciences Holdings' Operating Expenses (Quarterly) stood at $73.9 million in 2021, then rose by 29.18% to $95.5 million in 2022, then declined by 14.85% to $81.3 million in 2023, then surged by 155.83% to $208.0 million in 2024, then plummeted by 76.40% to $46.7 million in 2025.
  • Its Operating Expenses stands at $46.7 million for Q3 2025, versus $113.7 million for Q2 2025 and $96.0 million for Q1 2025.